3 min read
Cleerly: October 18, 2022
Half of patients who have a heart attack don't show symptoms prior to their event. A new standard of precision care that emphasizes comprehensive evaluation of atherosclerotic plaque for guiding personalized treatment and tracking heart disease over time...
3 min read
James K. Min, MD, FACC, FESC, MSCCT, Founder & CEO of Cleerly: September 19, 2022
Myocardial perfusion, also known as a "stress test", is today's go-to-method for detecting coronary artery disease - despite limited performance.
7 min read
James K. Min, MD, FACC, FESC, MSCCT, Founder & CEO of Cleerly: August 1, 2022
The current approach to cardiovascular care is flawed for two reasons. One is the lack of a disease-based care paradigm with a focus on actual heart disease–atherosclerosis– in lieu of an emphasis on symptom-driven care that identifies only late-stage...
3 min read
Last week, our team at Cleerly had the opportunity to take part in a gathering of impassioned cardiac computed tomography (CT) leaders at the Society of Cardiovascular Computed Tomography (SCCT) Annual Scientific Meeting in Las Vegas. As the former...
3 min read
Cleerly: June 8, 2022
Half of patients who have a heart attack don't show symptoms prior to their event. A new standard of precision care, emphasizing comprehensive evaluation of atherosclerotic plaque and heart attack prevention, is changing the approach to heart health.
2 min read
Cleerly: May 19, 2022
For the last 50 years, cardiology care has focused on treating symptoms of heart disease, rather than its root cause - atherosclerosis. At Cleerly, we are transforming the approach to cardiovascular care with our precision health model that proactively...
